Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system

Autor: Ilinykh PA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Huang K; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Gunn BM; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Kuzmina NA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Kedarinath K; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Jurado-Cobena E; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Zhou F; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Subramani C; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA., Hyde MA; Galveston National Laboratory, Galveston, TX, USA., Velazquez JV; Paul G. Allen School of Global Health, Washington State University, Pullman, WA, USA., Williamson LE; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Gilchuk P; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Carnahan RH; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Alter G; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. Galit.Alter@modernatx.com., Crowe JE Jr; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org., Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA. alexander.bukreyev@utmb.edu.; Galveston National Laboratory, Galveston, TX, USA. alexander.bukreyev@utmb.edu.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. alexander.bukreyev@utmb.edu.

Publikováno v: Communications biology [Commun Biol] 2024 Jul 17; Vol. 7 (1), pp. 871. Date of Electronic Publication: 2024 Jul 17.

OROPOUCHE VIRUS: MORE QUESTIONS THAN ANSWERS.

Autor: Jurado-Cobena E; Department of Microbiology & Immunology, Graduate School of Biomedical Science.; Department of Biostatistics & Data Science, School of Public and Population Health University of Texas Medical Branch at Galveston, Galveston. TX, USA.

Publikováno v: Zoonoses (Burlington, Mass.) [Zoonoses (Burlingt)] 2024 Jan; Vol. 4 (1). Date of Electronic Publication: 2024 Jul 30.

Evaluations of rationally designed rift valley fever vaccine candidate RVax-1 in mosquito and rodent models.

Autor: Ikegami T; Department of Pathology, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA. teikegam@utmb.edu.; The Sealy Institute for Vaccine Sciences, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA. teikegam@utmb.edu.; The Center for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA. teikegam@utmb.edu., Jurado-Cobena E; Department of Microbiology and Immunology, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA., Alkan C; Department of Pathology, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA., Smith JK; Department of Pathology, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA., Zhang L; Department of Pathology, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA., Kalveram B; Department of Pathology, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA., Juelich TL; Department of Pathology, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA., Esterly AT; Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.; SUNY Center for Vector-Borne Diseases, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.; Institute for Global Health and Translational Science, SUNY Upstate Medical University, Syracuse, NY, 13210, USA., Bhaskar JR; Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.; SUNY Center for Vector-Borne Diseases, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.; Institute for Global Health and Translational Science, SUNY Upstate Medical University, Syracuse, NY, 13210, USA., Thangamani S; Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.; SUNY Center for Vector-Borne Diseases, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.; Institute for Global Health and Translational Science, SUNY Upstate Medical University, Syracuse, NY, 13210, USA., Freiberg AN; Department of Pathology, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA.; The Sealy Institute for Vaccine Sciences, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA.; The Center for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX, 77555, USA.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2022 Sep 21; Vol. 7 (1), pp. 109. Date of Electronic Publication: 2022 Sep 21.

Analysis of 315 katG gene mutation in isoniazid-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis from Ecuador

Autor: Morey, G., Nicola-Salas, E., Parraga, K., Jurado-Cobena, E.

Publikováno v: In International Journal of Infectious Diseases August 2018 73 Supplement:348-348

Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus.

Autor: Alkan, Cigdem¹ (AUTHOR) cialkany@utmb.edu, O'Brien, Terrence² (AUTHOR) obrien.terry@gene.com, Kenyon, Victor³ (AUTHOR) victor@atomwise.com, Ikegami, Tetsuro^1,4,5 (AUTHOR) teikegam@utmb.edu

Publikováno v: Viruses (1999-4915). Jan2024, Vol. 16 Issue 1, p88. 14p.